🇺🇸 FDA
Patent

US 10736969

Multi-arm polymeric prodrug conjugates of pemetrexed-based compounds

granted A61KA61K47/60A61P

Quick answer

US patent 10736969 (Multi-arm polymeric prodrug conjugates of pemetrexed-based compounds) held by Nektar Therapeutics expires Mon Aug 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Aug 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K47/60, A61P, A61P35/00